REPLY: The Impact of Patiromer on Heart Failure Treatment With Angiotensin Inhibitors and MRAs

被引：0

作者：

Pitt, Bertram ^{[1
]}

Budden, Jeffrey ^{[2
]}

Anker, Stefan D. ^{[3
]}

Butler, Javed ^{[4
]}

机构：

[1] Univ Michigan, Ann Arbor, MI USA

[2] CSL Vifor, Redwood City, CA USA

[3] Charite, Inst Hlth Ctr Regenerat Therapies, German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany

[4] Univ Mississippi, Jackson, MS USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2025年 / 85卷 / 10期

关键词：

D O I：

10.1016/j.jacc.2024.12.029

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：e115 / e115

页数：1

共 50 条

[11] Safety and Prognostic Impact of Early Treatment with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Acute Heart Failure
Yoshioka, Kenji
Matsue, Yuya
Yamaguchi, Tetsuo
Kitai, Takeshi
Kagiyama, Nobuyuki
Okumura, Takahiro
Kida, Keisuke
Oishi, Shogo
Akiyama, Eiichi
Suzuki, Satoshi
Yamamoto, Masayoshi
Kuroda, Shunsuke
Matsumura, Akihiko
Hirao, Kenzo
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2019, 19 (06) : 597 - 605
[12] Comparison of angiotensin-converting enzyme inhibitors in the treatment of congestive heart failure
Tu, K
Mamdani, M
Kopp, A
Lee, D
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (02): : 283 - 286
[13] ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS (ACE) IN CONGESTIVE-HEART-FAILURE - REPLY
DEEDWANIA, PC
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (08) : 1670 - 1670
[14] Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure - Reply
Hudson, Marie
Rahme, Elham
Behlouli, Hassan
Sheppard, Richard
Pilote, Louise
EUROPEAN JOURNAL OF HEART FAILURE, 2007, 9 (09) : 964 - 964
[15] Impact of Ethnicity and Race on Response to Angiotensin-Converting Enzyme Inhibitors in Heart Failure
Campbell, Patrick
Ventura, Hector O.
JOURNAL OF CARDIAC FAILURE, 2015, 21 (06) : 457 - 459
[16] Are angiotensin-converting enzyme inhibitors and β-blockers making an impact on the epidemiology of heart failure?
Adams Jr. K.F.
Current Cardiology Reports, 2004, 6 (3) : 162 - 168
[17] Is there a place for angiotensin receptor-neprilysin inhibitors in the treatment of heart failure patients after heart transplantation?
Gulin, Dario
Planinic, Zrinka
Habek, Jasna Cerkez
Sikic, Jozica
INDIAN JOURNAL OF PHARMACOLOGY, 2019, 51 (06) : 413 - 415
[18] Pharmacoeconomics of angiotensin converting enzyme inhibitors in heart failure
Szucs, TD
AMERICAN JOURNAL OF HYPERTENSION, 1997, 10 (10) : S272 - S279
[19] RISK OF HYPOTENSION IN THE TREATMENT OF HEART-FAILURE WITH ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS
OSTERZIEL, KJ
DIETZ, R
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1993, 118 (03) : 65 - 68
[20] Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?
Houghton, AR
Cowley, AJ
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1997, 59 (01) : 7 - 10

← 1 2 3 4 5 →